Results 11 to 20 of about 7,043,555 (280)

Growth Hormone Deficiency in the Transition Period

Endocrinology Research and Practice, 2019
The importance of continuing growth hormone therapy in the transition and adulthood periods must be studied in adolescents with growth hormone deficiency with childhood onset.
Doğuş VURALLI
doaj   +2 more sources

Growth Hormone Deficiency in Adults

Endocrinology Research and Practice
Growth hormone deficiency (GHD) is the most frequently occurring pituitary hormone deficiency. Lesions in the hypothalamo-pituitary region and their treatment, pituitary apoplexy, empty sella, Sheehan’s syndrome, traumatic brain injury, infective ...
Emre Urhan, Kursad Unluhizarci, Fahrettin Kelestimur   +2 more
doaj   +2 more sources

Alterations in Cortical Thickness in Young Male Patients With Childhood-Onset Adult Growth Hormone Deficiency: A Morphometric MRI Study [PDF]

Frontiers in Neuroscience, 2019
BackgroundThe growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis plays an important role in brain structure and maintenance of brain function.
Hongbo Yang, Kang Li, Xinyu Liang, Bin Gu, Linjie Wang, Gaolang Gong, Feng Feng, Hui You, Bo Hou, Fengying Gong, Huijuan Zhu, Hui Pan   +11 more
doaj   +2 more sources

Diagnosing Growth Hormone Deficiency in Adults [PDF]

International Journal of Endocrinology, 2012
Adult growth hormone (GH) deficiency is a recognised syndrome associated with adverse phenotypic, metabolic, and quality-of-life features which improve in many patients when GH is substituted.
Nigel Glynn, Amar Agha
doaj   +3 more sources

Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan

Drug Design, Development and Therapy
Bradley S Miller,1 Jo Blair,2 Reiko Horikawa,3 Agnès Linglart,4– 7 Kevin CJ Yuen8 1Division of Pediatric Endocrinology, University of Minnesota Medical School, MHealth Fairview Masonic Children’s Hospital, Minneapolis, MN, USA; 2Department of Paediatric ...
Miller BS, Blair J, Horikawa R, Linglart A, Yuen KC   +4 more
doaj   +1 more source

Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation [PDF]

Frontiers in Endocrinology, 2023
Martin Bidlingmaier, Beverly M.K. Biller, David Clemmons, Jens Otto L. Jørgensen, Hiroshi Nishioka, Yutaka Takahashi, Yutaka Takahashi   +6 more
doaj   +2 more sources

Criteria for First-Year Growth Response to Growth Hormone Treatment in Prepubertal Children With Growth Hormone Deficiency: Do They Predict Poor Adult Height Outcome?

Frontiers in Endocrinology, 2019
Objective: Several criteria for first-year growth response (FYGR) to growth hormone (GH) treatment have been proposed. We explored which FYGR criteria predicted best the final height outcome after GH treatment in prepubertal children with GH deficiency ...
Saartje Straetemans, Saartje Straetemans, Saartje Straetemans, Jean De Schepper, Jean De Schepper, Jean De Schepper, Muriel Thomas, Sylvie Tenoutasse, Sylvie Tenoutasse, Véronique Beauloye, Véronique Beauloye, Raoul Rooman, Raoul Rooman   +12 more
doaj   +3 more sources

Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients’ Perspective [PDF]

Journal of the Endocrine Society, 2022
Maria Fleseriu, Andrew Hoffman, Nicky Kelepouris   +2 more
exaly   +2 more sources

Differentiation of adult-type Leydig cells occurs in gonadotrophin-deficient mice [PDF]

, 2003
During mammalian testis development distinct generations of fetal and adult Leydig cells arise. Luteinising hormone (LH) is required for normal adult Leydig cell function and for the establishment of normal adult Leydig cell number but its role in the ...
Baker, P.J., Johnston, H., Abel, M., Charlton, H.M., O'Shaughnessy, P.J.   +4 more
core   +9 more sources

Adult growth hormone deficiency [PDF]

Clinical Medicine, 2003
Growth hormone deficiency (GHD) in adults arises as a consequence of decreased secretion of somatotropin (GH) from the anterior pituitary. The diagnosis of GHD is dependent on the demonstration of a subnormal rise in serum GH in response to one or more dynamic stimulation tests in the presence of co-existing pituitary disease or other pituitary hormone
A M, Brooke, J P, Monson
openaire   +2 more sources